Identification and functional assessment of BCRP polymorphisms in a Korean population

被引:45
作者
Lee, Sang Seop
Jeong, Hye-Eun
Yi, Joo-Mi
Jung, Hyun-Ju
Jang, Jae-Eun
Kim, Eun-Young
Lee, Su-Jun
Shin, Jae-Gook
机构
[1] Inje Univ, Coll Med, Busan Paik Hosp, Dept Pharmacol, Pusan, South Korea
[2] Inje Univ, Coll Med, Busan Paik Hosp, Pharmacogenom Res Ctr, Pusan, South Korea
[3] Inje Univ, Coll Med, Busan Paik Hosp, Dept Clin Pharmacol, Pusan, South Korea
关键词
D O I
10.1124/dmd.106.012302
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The breast cancer resistance protein ( BCRP) is a member of the ATP-binding cassette transporters. The aim of the present study was to identify genetic variants of BCRP in Koreans and to assess the functional consequences of BCRP polymorphisms. Twenty single nucleotide polymorphisms ( SNP), including four nonsynonymous SNP, were identified by DNA sequencing of the BCRP gene in 92 Korean subjects. BCRP V12M, Q141K, P269S, and Q126Stop were detected at frequencies of 23, 28, 0.2, and 1.9%, respectively. These four coding variants were also screened in Chinese and Vietnamese subjects; the allelic frequencies among the three populations were compared; and predictions were made as to the potential frequency of each variant. In vitro functional analyses of the P269S protein and the promoter SNP - 19031C > T ( mutated in the hypoxia-inducible factor-1 alpha binding site) were performed and compared with those of the wild type. P269S exhibited a 35 to 40% decrease in vesicular uptake of [H-3] estrone-3-sulfate and [H-3] methotrexate compared with the wild type. The promoter SNP - 19031C > T did not affect BCRP promoter activity in either the presence or absence of chemical-induced hypoxic stress. Our results suggest that the P269S variant could be a functionally altered variant. Genotyping of this variant in clinical studies is needed to address its phenotypic role. Genetic polymorphisms of BCRP were found to be very common in Koreans, as well as in other ethnic groups. Comparative analyses among three Asian populations revealed different frequencies for the four functional BCRP variants.
引用
收藏
页码:623 / 632
页数:10
相关论文
共 35 条
[1]  
AI T, 2006, MOL PHARM, V70, P287
[2]  
Allikmets R, 1998, CANCER RES, V58, P5337
[3]   Genetic variation in the ATP-binding Cassette Transporter gene ABCG2 (BCRP) in a Swedish population [J].
Bäckström, G ;
Taipalensuu, J ;
Melhus, H ;
Brändström, H ;
Svensson, AC ;
Artursson, P ;
Kindmark, A .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 18 (05) :359-364
[4]   Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene [J].
Bailey-Dell, KJ ;
Hassel, B ;
Doyle, LA ;
Ross, DD .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2001, 1520 (03) :234-241
[5]   The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target [J].
Blancher, C ;
Harris, AL .
CANCER AND METASTASIS REVIEWS, 1998, 17 (02) :187-194
[6]  
Brangi M, 1999, CANCER RES, V59, P5938
[7]   A multidrug resistance transporter from human MCF-7 breast cancer cells [J].
Doyle, LA ;
Yang, WD ;
Abruzzo, LV ;
Krogmann, T ;
Gao, YM ;
Rishi, AK ;
Ross, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15665-15670
[8]   Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1) [J].
Honjo, Y ;
Morisaki, K ;
Huff, LM ;
Robey, RW ;
Hung, J ;
Dean, M ;
Bates, SE .
CANCER BIOLOGY & THERAPY, 2002, 1 (06) :696-702
[9]  
Honjo Y, 2001, CANCER RES, V61, P6635
[10]  
Imai Y, 2002, MOL CANCER THER, V1, P611